Testing for t(3;8) in MYC/BCL6 re-arranged large B cell lymphoma identifies a high risk subgroup with inferior survival. Maybury BD, James LJ BSc (Hons), Phillips N, Venkatadasari I, et al. Blood 2024 Apr 22:blood.2024024048. doi: 10.1182/blood.2024024048.

Read + Share

Amedeo Smart

Independent Medical Education

Maybury BD, James LJ BSc (Hons), Phillips N, Venkatadasari I, et al. Testing for t(3;8) in MYC/BCL6 re-arranged large B cell lymphoma identifies a high risk subgroup with inferior survival. Blood 2024 Apr 22:blood.2024024048. doi: 10.1182/blood.2024024048.
PMID: 38648564